Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification.
Klatte T, Said JW, de Martino M, Larochelle J, Shuch B, Rao JY, Thomas GV, Kabbinavar FF, Belldegrun AS, Pantuck AJ. Klatte T, et al. Among authors: kabbinavar ff. J Urol. 2009 Apr;181(4):1558-64; discussion 1563-4. doi: 10.1016/j.juro.2008.11.098. Epub 2009 Feb 23. J Urol. 2009. PMID: 19230920
Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience.
Klatte T, Wunderlich H, Patard JJ, Kleid MD, Lam JS, Junker K, Schubert J, Böhm M, Allhoff EP, Kabbinavar FF, Crepel M, Cindolo L, De La Taille A, Tostain J, Mejean A, Soulie M, Bellec L, Bernhard JC, Ferriere JM, Pfister C, Albouy B, Colombel M, Zisman A, Belldegrun AS, Pantuck AJ. Klatte T, et al. Among authors: kabbinavar ff. BJU Int. 2007 Jul;100(1):21-5. doi: 10.1111/j.1464-410X.2007.06877.x. Epub 2007 Apr 13. BJU Int. 2007. PMID: 17433034
Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval.
Klatte T, Patard JJ, Wunderlich H, Goel RH, Lam JS, Junker K, Schubert J, Böhm M, Allhoff EP, Kabbinavar FF, Crepel M, Cindolo L, De La Taille A, Tostain J, Mejean A, Soulie M, Bellec L, Bernhard JC, Ferriere JM, Pfister C, Albouy B, Colombel M, Zisman A, Belldegrun AS, Pantuck AJ. Klatte T, et al. Among authors: kabbinavar ff. J Urol. 2007 Jun;177(6):2081-6; discussion 2086-7. doi: 10.1016/j.juro.2007.01.122. J Urol. 2007. PMID: 17509291
Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
Klatte T, Patard JJ, Goel RH, Kleid MD, Guille F, Lobel B, Abbou CC, De La Taille A, Tostain J, Cindolo L, Altieri V, Ficarra V, Artibani W, Prayer-Galetti T, Allhoff EP, Schips L, Zigeuner R, Figlin RA, Kabbinavar FF, Pantuck AJ, Belldegrun AS, Lam JS. Klatte T, et al. Among authors: kabbinavar ff. J Urol. 2007 Jul;178(1):35-40; discussion 40. doi: 10.1016/j.juro.2007.03.046. Epub 2007 May 22. J Urol. 2007. PMID: 17521678
Prognostic factors for renal cell carcinoma with tumor thrombus extension.
Klatte T, Pantuck AJ, Riggs SB, Kleid MD, Shuch B, Zomorodian N, Kabbinavar FF, Belldegrun AS. Klatte T, et al. Among authors: kabbinavar ff. J Urol. 2007 Oct;178(4 Pt 1):1189-95; discussion 1195. doi: 10.1016/j.juro.2007.05.134. Epub 2007 Aug 14. J Urol. 2007. PMID: 17698087
Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Klatte T, Seligson DB, Riggs SB, Leppert JT, Berkman MK, Kleid MD, Yu H, Kabbinavar FF, Pantuck AJ, Belldegrun AS. Klatte T, et al. Among authors: kabbinavar ff. Clin Cancer Res. 2007 Dec 15;13(24):7388-93. doi: 10.1158/1078-0432.CCR-07-0411. Clin Cancer Res. 2007. PMID: 18094421
Pathobiology and prognosis of chromophobe renal cell carcinoma.
Klatte T, Han KR, Said JW, Böhm M, Allhoff EP, Kabbinavar FF, Belldegrun AS, Pantuck AJ. Klatte T, et al. Among authors: kabbinavar ff. Urol Oncol. 2008 Nov-Dec;26(6):604-9. doi: 10.1016/j.urolonc.2007.07.015. Epub 2008 Jan 14. Urol Oncol. 2008. PMID: 18367104
111 results